The Scientific Basis for the Regulation of Flavors in Tobacco Products
Bold K, Kong G, O'Malley S. The Scientific Basis for the Regulation of Flavors in Tobacco Products. Annual Review Of Clinical Psychology 2024, 20: 381-406. PMID: 38346292, PMCID: PMC11446566, DOI: 10.1146/annurev-clinpsy-080921-075624.Peer-Reviewed Original ResearchTobacco policiesTobacco productsTobacco useReduce tobacco-related health disparitiesTobacco-related health disparitiesFlavored tobacco productsMenthol tobacco productsHealth disparitiesFood and Drug AdministrationEvidence-based policyClinical research methodsMenthol cigarettesClinical sciencePublic healthTobaccoPopulation levelScientific evidencePublication dateRegulation of flavorClinical researchUS Food and Drug AdministrationProtect public healthAnnual ReviewExpected final online publication dateTobacco marketplaceDiscordance Between Insurance Coverage of Antiviral Medications and Nicotine Replacement Therapy Among Individuals With Human Immunodeficiency Virus Who Smoke
Bernstein S, Yager J, Sigel K, Porter E, Do T, Payne E, Bold K, Ledgerwood D, Edelman E. Discordance Between Insurance Coverage of Antiviral Medications and Nicotine Replacement Therapy Among Individuals With Human Immunodeficiency Virus Who Smoke. Journal Of Addiction Medicine 2024, 18: 404-407. PMID: 38606851, PMCID: PMC11290992, DOI: 10.1097/adm.0000000000001302.Peer-Reviewed Original ResearchNicotine replacement therapyHuman immunodeficiency virusTobacco use disorderAntiretroviral therapyReplacement therapyTobacco useImmunodeficiency virusCoverage of antiretroviral therapyInsurance coverageSecondary analysis of dataUse disorderManaged care planOut-of-pocketMandated insurance coverageCare planningEfficacy of antiviralsRandomized clinical trialsPharmacy benefit managersInsurance barriersMedication prescriptionsSecondary analysisTracking formParticipation AssessmentAntiviral medicationsPWHAn Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment: Beyond Dichotomous Point-Prevalence Outcomes
Kypriotakis G, Bernstein S, Bold K, Dziura J, Hedeker D, Mermelstein R, Weinberger A. An Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment: Beyond Dichotomous Point-Prevalence Outcomes. Nicotine & Tobacco Research 2024, 26: 796-805. PMID: 38214037, PMCID: PMC11190044, DOI: 10.1093/ntr/ntae005.Peer-Reviewed Original ResearchSmoking cessation treatmentChronic relapsing conditionCessation treatmentRelapsing conditionSmoking cessation clinical trialMeasures of abstinenceTobacco useAbstinence outcomesTobacco dependence treatmentTobacco abstinenceTobacco dependenceTobacco outcomesDependence treatmentTreatment studiesAbstinenceSmoking cessationClinical trialsIntervention successParticipant enrollmentSociety for ResearchNicotineLongitudinal dataResearch NetworkRemitting natureAnalysis of data